$488 Million is the total value of Bellevue Group AG's 122 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 7.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $23,109,000 | +13.8% | 199,650 | +2.8% | 4.73% | +29.0% |
| SYK | Sell | STRYKER CORP | $18,618,000 | -11.5% | 155,400 | -14.0% | 3.81% | +0.3% |
| MDT | Buy | MEDTRONIC PLC | $18,484,000 | -13.6% | 259,500 | +4.8% | 3.78% | -2.0% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $17,604,000 | +26.8% | 110,000 | +10.9% | 3.60% | +43.7% |
| ABT | Buy | ABBOTT LABS | $15,575,000 | -4.1% | 405,500 | +5.6% | 3.19% | +8.7% |
| INCY | Buy | INCYTE CORP | $15,081,000 | +75.8% | 150,400 | +65.3% | 3.09% | +99.2% |
| BIIB | Sell | BIOGEN INC | $13,895,000 | -18.6% | 49,000 | -10.1% | 2.84% | -7.7% |
| GILD | Buy | GILEAD SCIENCES INC | $12,854,000 | +3.8% | 179,500 | +14.7% | 2.63% | +17.7% |
| LGND | Buy | LIGAND PHARAMCEUTICALS INC | $12,653,000 | +16.0% | 124,530 | +16.5% | 2.59% | +31.5% |
| AMGN | AMGEN INC | $12,209,000 | -12.3% | 83,500 | 0.0% | 2.50% | -0.7% | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $11,896,000 | -13.1% | 550,000 | -4.3% | 2.44% | -1.5% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $11,857,000 | -22.4% | 32,300 | -15.0% | 2.43% | -12.0% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $11,712,000 | +14.3% | 125,000 | +47.1% | 2.40% | +29.5% |
| BCR | Buy | BARD C R INC | $11,480,000 | +104.7% | 51,100 | +104.4% | 2.35% | +132.1% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $10,630,000 | +2.2% | 103,000 | +28.8% | 2.18% | +15.9% |
| AKRXQ | Buy | AKORN INC | $10,042,000 | +46.2% | 460,000 | +82.5% | 2.06% | +65.7% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $9,137,000 | -10.2% | 83,800 | 0.0% | 1.87% | +1.7% | |
| MYL | MYLAN N V | $8,992,000 | +0.1% | 235,700 | 0.0% | 1.84% | +13.4% | |
| HOLX | Sell | HOLOGIC INC | $8,810,000 | -6.3% | 219,600 | -9.3% | 1.80% | +6.2% |
| CNC | Buy | CENTENE CORP DEL | $8,569,000 | -9.5% | 151,630 | +7.2% | 1.76% | +2.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $8,518,000 | -1.1% | 234,990 | +25.5% | 1.74% | +12.1% |
| BAX | BAXTER INTL INC | $8,425,000 | -6.8% | 190,000 | 0.0% | 1.72% | +5.6% | |
| ILMN | Sell | ILLUMINA INC | $6,889,000 | -59.9% | 53,800 | -43.1% | 1.41% | -54.5% |
| BDX | Sell | BECTON DICKINSON & CO | $6,622,000 | -33.0% | 40,000 | -27.3% | 1.36% | -24.1% |
| AGN | ALLERGAN PLC | $6,174,000 | -8.8% | 29,400 | 0.0% | 1.26% | +3.4% | |
| ALXN | ALEXION PHARMACEUTICALS INC | $6,044,000 | -0.1% | 49,400 | 0.0% | 1.24% | +13.2% | |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,967,000 | -19.5% | 81,000 | -4.7% | 1.22% | -8.7% |
| DHR | New | DANAHER CORP DEL | $5,760,000 | – | 74,000 | +100.0% | 1.18% | – |
| ISRG | Sell | INTUITIVE SURGICAL INC | $5,708,000 | -34.4% | 9,000 | -25.0% | 1.17% | -25.6% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $5,385,000 | -10.5% | 65,000 | 0.0% | 1.10% | +1.5% | |
| ABMD | Sell | ABIOMED INC | $5,076,000 | -28.8% | 45,050 | -18.8% | 1.04% | -19.3% |
| CI | Sell | CIGNA CORPORATION | $5,032,000 | -35.3% | 37,722 | -36.8% | 1.03% | -26.7% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $4,926,000 | -8.9% | 175,000 | -13.4% | 1.01% | +3.3% |
| CERN | CERNER CORP | $4,666,000 | -23.3% | 98,500 | 0.0% | 0.96% | -13.0% | |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $4,665,000 | -31.2% | 375,000 | -24.2% | 0.96% | -22.0% |
| JNJ | Sell | JOHNSON & JOHNSON | $4,378,000 | -25.9% | 38,000 | -24.0% | 0.90% | -15.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $4,353,000 | +10.0% | 91,000 | -15.7% | 0.89% | +24.6% |
| SHPG | Sell | SHIRE PLCsponsored adr | $4,089,000 | -44.6% | 24,000 | -37.0% | 0.84% | -37.3% |
| MNKKQ | MALLINCKRODT PUB LTD CO | $4,025,000 | -28.6% | 80,800 | 0.0% | 0.82% | -19.1% | |
| COO | Sell | COOPER COS INC | $3,499,000 | -16.9% | 20,000 | -14.9% | 0.72% | -5.8% |
| ESRX | EXPRESS SCRIPTS HLDG CO | $3,405,000 | -2.5% | 49,500 | 0.0% | 0.70% | +10.5% | |
| MCK | MCKESSON CORP | $3,371,000 | -15.8% | 24,000 | 0.0% | 0.69% | -4.6% | |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $3,229,000 | +59.1% | 40,700 | +40.3% | 0.66% | +80.1% |
| HUM | Buy | HUMANA INC | $3,162,000 | +65.5% | 15,500 | +43.5% | 0.65% | +87.8% |
| HALO | HALOZYME THERAPEUTICS INC | $3,142,000 | -18.2% | 318,000 | 0.0% | 0.64% | -7.3% | |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $3,023,000 | -0.9% | 43,000 | 0.0% | 0.62% | +12.3% | |
| ANTM | ANTHEM INC | $2,962,000 | +14.8% | 20,600 | 0.0% | 0.61% | +30.3% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $2,902,000 | -1.2% | 75,000 | +29.3% | 0.59% | +11.9% |
| ZLTQ | ZELTIQ AESTHETICS INC | $2,611,000 | +11.0% | 60,000 | 0.0% | 0.54% | +25.9% | |
| LLY | LILLY ELI & CO | $2,574,000 | -8.4% | 35,000 | 0.0% | 0.53% | +3.7% | |
| QGEN | QIAGEN NV | $2,564,000 | +2.1% | 91,500 | 0.0% | 0.52% | +15.6% | |
| DXCM | New | DEXCOM INC | $2,448,000 | – | 41,000 | +100.0% | 0.50% | – |
| PRGO | Sell | PERRIGO CO PLC | $2,414,000 | -38.8% | 29,000 | -32.1% | 0.49% | -30.6% |
| ALKS | Sell | ALKERMES PLC | $2,362,000 | -2.5% | 42,500 | -17.5% | 0.48% | +10.5% |
| NUVA | Sell | NUVASIVE INC | $2,358,000 | -41.0% | 35,000 | -41.7% | 0.48% | -33.2% |
| EARS | AURIS MED HLDG AG | $2,321,000 | -38.2% | 2,169,625 | 0.0% | 0.48% | -29.9% | |
| NKTR | NEKTAR THERAPEUTICS | $2,282,000 | -28.6% | 186,000 | 0.0% | 0.47% | -19.1% | |
| SGEN | SEATTLE GENETICS INC | $2,269,000 | -2.3% | 43,000 | 0.0% | 0.46% | +10.7% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $2,258,000 | -11.3% | 16,000 | 0.0% | 0.46% | +0.4% | |
| GMED | GLOBUS MED INCcl a | $2,176,000 | +10.0% | 87,700 | 0.0% | 0.45% | +24.6% | |
| ENDP | Sell | ENDO INTL PLC | $2,042,000 | -46.7% | 124,000 | -34.7% | 0.42% | -39.6% |
| AET | AETNA INC NEW | $2,034,000 | +7.4% | 16,400 | 0.0% | 0.42% | +21.9% | |
| MASI | Sell | MASIMO | $2,022,000 | -51.4% | 30,000 | -57.1% | 0.41% | -44.9% |
| PRTA | PROTHENA CORP PLC | $2,017,000 | -18.0% | 41,000 | 0.0% | 0.41% | -7.0% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $1,878,000 | -21.0% | 45,000 | 0.0% | 0.38% | -10.3% | |
| ALR | Buy | ALERE INC | $1,870,000 | +44.2% | 47,983 | +59.9% | 0.38% | +63.7% |
| BLUE | BLUEBIRD BIO INC | $1,789,000 | -9.0% | 29,000 | 0.0% | 0.37% | +3.1% | |
| HCA | Sell | HCA HOLDINGS INC | $1,762,000 | -25.3% | 23,800 | -23.7% | 0.36% | -15.3% |
| ANGO | Sell | ANGIODYNAMICS INC | $1,716,000 | -24.7% | 101,700 | -21.8% | 0.35% | -14.8% |
| MGNX | MACROGENICS INC | $1,697,000 | -31.7% | 83,000 | 0.0% | 0.35% | -22.5% | |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $1,631,000 | -38.7% | 230,000 | 0.0% | 0.33% | -30.6% | |
| PFE | PFIZER INC | $1,624,000 | -4.1% | 50,000 | 0.0% | 0.33% | +8.8% | |
| MRK | Sell | MERCK & CO INC | $1,619,000 | -44.8% | 27,500 | -41.5% | 0.33% | -37.4% |
| XENT | Sell | INTERSECT ENT INC | $1,573,000 | -51.6% | 130,000 | -36.7% | 0.32% | -45.2% |
| RDUS | Sell | RADIUS HEALTH INC | $1,521,000 | -53.9% | 40,000 | -34.4% | 0.31% | -47.8% |
| HCSG | HEALTHCARE SVCS GRP INC | $1,492,000 | -1.1% | 38,100 | 0.0% | 0.31% | +12.5% | |
| CAH | Sell | CARDINAL HEALTH INC | $1,439,000 | -83.8% | 20,000 | -82.5% | 0.30% | -81.6% |
| BMY | BRISTOL MYERS SQUIBB CO | $1,344,000 | +8.4% | 23,000 | 0.0% | 0.28% | +22.8% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $1,298,000 | -9.3% | 45,000 | 0.0% | 0.27% | +2.7% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $1,119,000 | +50.4% | 7,800 | +23.8% | 0.23% | +70.9% |
| INO | INOVIO PHARMACEUTICALS INC | $1,076,000 | -25.5% | 155,000 | 0.0% | 0.22% | -15.7% | |
| INSYQ | INSYS THERAPEUTICS INC NEW | $1,058,000 | -22.0% | 115,000 | 0.0% | 0.22% | -11.4% | |
| IBB | Sell | ISHARES TRnasdq biotec etf | $1,062,000 | -72.8% | 4,000 | -70.4% | 0.22% | -69.3% |
| TFX | TELEFLEX INC | $1,047,000 | -4.1% | 6,500 | 0.0% | 0.21% | +8.6% | |
| LH | LABORATORY CORP AMER HLDGS | $1,027,000 | -6.6% | 8,000 | 0.0% | 0.21% | +5.5% | |
| ACHN | ACHILLION PHARMACEUTICALS IN | $991,000 | -49.0% | 240,000 | 0.0% | 0.20% | -42.2% | |
| ABBV | ABBVIE INC | $939,000 | -0.7% | 15,000 | 0.0% | 0.19% | +12.3% | |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $924,000 | -58.4% | 8,500 | -37.0% | 0.19% | -52.9% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $899,000 | -44.7% | 24,000 | 0.0% | 0.18% | -37.4% | |
| MOH | MOLINA HEALTHCARE INC | $895,000 | -7.0% | 16,500 | 0.0% | 0.18% | +5.2% | |
| EXEL | EXELIXIS INC | $895,000 | +16.7% | 60,000 | 0.0% | 0.18% | +31.7% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $888,000 | -42.7% | 20,000 | -53.5% | 0.18% | -35.0% |
| EVHC | Sell | ENVISION HEALTHCARE HLDGS INC | $824,000 | -5.2% | 13,026 | -66.6% | 0.17% | +7.6% |
| BIB | Sell | PROSHARES TR | $818,000 | -62.9% | 20,500 | -54.9% | 0.17% | -57.8% |
| PTLA | PORTOLA PHARMACEUTICALS INC | $808,000 | -1.2% | 36,000 | 0.0% | 0.16% | +11.5% | |
| LABU | DIREXION SHS ETF TRsp biotech bl new | $788,000 | -35.8% | 25,175 | 0.0% | 0.16% | -27.5% | |
| CVS | CVS HEALTH CORP | $765,000 | -11.4% | 9,700 | 0.0% | 0.16% | +0.6% | |
| JUNO | JUNO THERAPEUTICS INC | $697,000 | -37.2% | 37,000 | 0.0% | 0.14% | -28.9% | |
| GKOS | New | GLAUKOS CORP | $686,000 | – | 20,000 | +100.0% | 0.14% | – |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $686,000 | -36.5% | 33,000 | 0.0% | 0.14% | -28.2% | |
| GWPH | GW PHARMACEUTICALS PLCads | $670,000 | -15.8% | 6,000 | 0.0% | 0.14% | -4.9% | |
| DVA | DAVITA INC | $642,000 | -2.9% | 10,000 | 0.0% | 0.13% | +10.1% | |
| KITE | KITE PHARMA INC | $628,000 | -19.7% | 14,000 | 0.0% | 0.13% | -8.5% | |
| VAR | VARIAN MED SYS INC | $628,000 | -9.9% | 7,000 | 0.0% | 0.13% | +2.4% | |
| NVRO | Buy | NEVRO CORP | $632,000 | -19.3% | 8,700 | +16.0% | 0.13% | -8.5% |
| PODD | INSULET CORP | $565,000 | -8.0% | 15,000 | 0.0% | 0.12% | +4.5% | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $566,000 | -12.4% | 160,000 | 0.0% | 0.12% | -0.9% | |
| New | REWALK ROBOTICS LTD | $560,000 | – | 200,000 | +100.0% | 0.12% | – | |
| QTNT | QUOTIENT LTD | $532,000 | -38.1% | 110,000 | 0.0% | 0.11% | -29.7% | |
| ESPR | ESPERION THERAPEUTICS INC NEW | $501,000 | -9.6% | 40,000 | 0.0% | 0.10% | +3.0% | |
| RMD | RESMED INC | $496,000 | -4.2% | 8,000 | 0.0% | 0.10% | +8.5% | |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $492,000 | -26.3% | 15,428 | -16.3% | 0.10% | -16.5% |
| NVAX | NOVAVAX INC | $410,000 | -39.3% | 325,000 | 0.0% | 0.08% | -31.1% | |
| HZNP | Sell | HORIZON PHARMA PLC | $388,000 | -81.7% | 24,000 | -79.5% | 0.08% | -79.4% |
| WBMD | WEBMD HEALTH CORP | $367,000 | -0.3% | 7,400 | 0.0% | 0.08% | +13.6% | |
| OBLN | New | OBALON THERAPEUTICS INC | $354,000 | – | 40,000 | +100.0% | 0.07% | – |
| AACH | AAC HLDGS INC | $326,000 | -58.4% | 45,000 | 0.0% | 0.07% | -52.5% | |
| PEN | PENUMBRA INC | $319,000 | -16.1% | 5,000 | 0.0% | 0.06% | -5.8% | |
| SGRY | SURGERY PARTNERS INC | $238,000 | -21.7% | 15,000 | 0.0% | 0.05% | -10.9% | |
| MYGN | MYRIAD GENETICS INC | $233,000 | -19.1% | 14,000 | 0.0% | 0.05% | -7.7% | |
| WMGI | Sell | WRIGHT MED GROUP NV | $230,000 | -86.7% | 10,000 | -85.8% | 0.05% | -84.9% |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $39,000 | -13.3% | 3,333 | 0.0% | 0.01% | 0.0% | |
| QHCCQ | Exit | Quorum Health Corp | $0 | – | -12,500 | -100.0% | -0.01% | – |
| TMH | Exit | Team Health Holdings Inc. | $0 | – | -25,000 | -100.0% | -0.15% | – |
| IPXL | Exit | Impax Laboratories, Inc. | $0 | – | -95,000 | -100.0% | -0.41% | – |
| AMSG | Exit | Amsurg Corp | $0 | – | -71,400 | -100.0% | -0.86% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.